Enveric Biosciences, Inc. Logo

Enveric Biosciences, Inc.

Develops novel small-molecule therapeutics for neuropsychiatric disorders.

ENVB | US

Overview

Corporate Details

ISIN(s):
US02362F3029 (+1 more)
LEI:
Country:
United States of America
Address:
245 FIRST STREET RIVERVIEW II 18TH FLOOR, 2142 CAMBRIDGE

Description

Enveric Biosciences is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of neuropsychiatric disorders. The company focuses on conditions such as anxiety, depression, and addiction. Leveraging its proprietary discovery and development platform, The Psybrary™, Enveric has created a robust intellectual property portfolio of novel molecules for specific mental health indications. Its development pipeline includes candidates such as EB-003 for difficult-to-treat mental health disorders and the EVM301 series.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-12 18:10
8-K
English 393.1 KB
2025-12-11 18:41
8-K
English 72.0 KB
2025-12-10 21:47 English 8.6 KB
2025-12-10 21:47 English 8.8 KB
2025-12-10 02:08
424B3
English 72.2 KB
2025-12-09 06:15 English 5.2 KB
2025-12-06 01:06 English 8.8 KB
2025-12-05 23:40 English 8.9 KB
2025-12-05 23:18
S-3/A
English 102.2 KB
2025-11-14 22:31
10-Q
English 912.7 KB
2025-11-14 22:05
8-K
English 64.2 KB
2025-11-14 22:05
8-K
English 96.7 KB
2025-11-13 21:42 English 9.6 KB
2025-10-27 21:30
DEF 14A
English 1.4 MB
2025-10-23 22:30
8-K
English 112.7 KB

Automate Your Workflow. Get a real-time feed of all Enveric Biosciences, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Enveric Biosciences, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Enveric Biosciences, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Adaptive Biotechnologies Corp Logo
Decodes the adaptive immune system to develop products for diagnosing and treating disease.
United States of America
ADPT
Adeia Inc. Logo
R&D company that licenses IP for the media, entertainment, and semiconductor industries.
United States of America
ADEA
Aditxt, Inc. Logo
Acquires, develops, and deploys health technologies to address major health challenges.
United States of America
ADTX
Advanced Biomed Inc. Logo
Develops microfluidic biochip diagnostic systems for precision oncology.
United States of America
ADVB
AIM ImmunoTech Inc. Logo
Immuno-pharma company developing therapeutics for oncology, immune, and viral diseases.
United States of America
AIM
Ainos, Inc. Logo
Develops AI-driven diagnostics, immune therapeutics, and telehealth POCT devices.
United States of America
AIMD
Akero Therapeutics, Inc. Logo
Clinical-stage company developing treatments for serious metabolic diseases like MASH.
United States of America
AKRO
Aladdin Healthcare Technologies SE Logo
Develops AI-powered tools for drug discovery and diagnostics for age-related conditions.
Germany
NMI
Alaunos Therapeutics, Inc. Logo
Clinical-stage immuno-oncology company developing TCR-T cell therapies for solid tumors.
United States of America
TCRT
Aligos Therapeutics, Inc. Logo
A clinical-stage biopharmaceutical company developing therapeutics for liver and viral diseases.
United States of America
ALGS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.